celiprolol has been researched along with candesartan cilexetil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, T; Kitaura, Y; Matsumura, Y; Mori, T; Ohkita, M; Okuda, N; Shimomura, H; Sohmiya, K; Yoshikawa, J; Yoshiyama, M | 1 |
| Bucas, V; Desfontis, JC; Gogny, M; Mallem, MY; Noireaud, J; Sauvaget, F | 1 |
2 other study(ies) available for celiprolol and candesartan cilexetil
| Article | Year |
|---|---|
Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Celiprolol; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Heart Failure; Male; Rats; Rats, Sprague-Dawley; Tetrazoles; Ventricular Remodeling | 2005 |
Positive influence of AT(1) receptor antagonism upon the impaired celiprolol-induced vasodilatation in aorta from spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Celiprolol; Dose-Response Relationship, Drug; Endothelium, Vascular; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tetrazoles; Vasodilation; Vasodilator Agents | 2010 |